chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Second Dose: left arm pain, couldn''t raise her arm; excruciating pain; felt like her arm was broken; Second Dose: extra pain in her shoulder area and forearm area that has radiated to the forearm, all on the left side. Caller states she shoulder is sore upon movement; Second Dose: forearm is almost like she has no ability to grip. Caller states like if she picks up milk, the pain shoots through her forearm, it is bizarre, she has almost no grip or strength.; movement was horrible; felt like her arm was broken; shoulder is sore upon movement; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 47 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 18Sep2021 10:00 (Lot number: FF2587) at the age of 47 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (First Dose, Lot: FC3184 or FL3184, Anatomical Location: Arm left), administration date: 28Aug2021, when the patient was 47 years old, for COVID-19 Immunization, reaction(s): "First Dose: left breast swelled up horribly on the left side", "First Dose: Normal Soreness, Tiredness, and Nausea", "First Dose: Normal Soreness, Tiredness, and Nausea", "First Dose: Normal Soreness, Tiredness, and Nausea". The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 18Sep2021, outcome "not recovered", described as "Second Dose: left arm pain, couldn''t raise her arm; excruciating pain; felt like her arm was broken"; ARTHRALGIA (non-serious) with onset 18Sep2021, outcome "not recovered", described as "Second Dose: extra pain in her shoulder area and forearm area that has radiated to the forearm, all on the left side. Caller states she shoulder is sore upon movement"; ASTHENIA (non-serious) with onset 18Sep2021, outcome "not recovered", described as "Second Dose: forearm is almost like she has no ability to grip. Caller states like if she picks up milk, the pain shoots through her forearm, it is bizarre, she has almost no grip or strength."; MOVEMENT DISORDER (non-serious) with onset 18Sep2021, outcome "not recovered", described as "movement was horrible"; FEELING ABNORMAL (non-serious) with onset 18Sep2021, outcome "not recovered", described as "felt like her arm was broken"; ARTHRALGIA (non-serious) with onset 18Sep2021, outcome "not recovered", described as "shoulder is sore upon movement". Therapeutic measures were taken as a result of pain in extremity, arthralgia, asthenia, movement disorder, feeling abnormal, arthralgia.  Additional information: Chiropractor and Stim machine hooks up to electrodes and blood flowing to that area, heat, ice. It is unknown if Additional Vaccines Administered on Same Date of the Pfizer Suspect. It is unknown if Prior Vaccinations within 4 weeks.  No follow-up attempts are possible. No further information is expected.
Nonstop headache that started within minutes of receiving the vaccine. It intensifies to causing nausea, trouble sleeping and sensitive to noise and light.
Around 5 AM on 11/4/01, pt woke up crying so father got up and fed him formula and cereal. Father laid in recliner with baby on chest. About an hour later when mother got up and went to where they were, she found the baby dead. Father upset "that he might have smothered the baby."
Patient received vaccine and went to sit down in front of pharmacy. He then immediately started feeling lightheaded, his eyes rolled into the back of this head and he had a couple of convulsion. He did not lose consciousness and was immediately aware. He was pale, lips were blue tinged, pulse was 60, sweating and blood pressure was 98/50. Paramedics were called but he had recovered by the time they got there. They said he had a fainting episode due to the vaccination and did not have a seizure. The patient had not eaten anything  the whole day and he felt that contributed. Followed up with patient's parent and he is feeling just fine now.
Information has been received from a medical assistant referring to an unspecified number of unspecified patients of unknown age and gender. In July 2015 (also reported as unspecified dates since 01-JUL-2015) the patients were administered an unspecified number of improperly stored doses of RECOMBIVAX HB (route, lot#, strength and dose were unknown). No adverse effect was reported. This is one of several reports received from the same reporter. Additional information has been requested.
pt recvd vax & exp a sl fever,nausea,& soreness all over;these sx subsided;01DEC94 recvd 3rd doses of vax w/adverse event;
Erythema and pain at the injection site, 11/18/10 possible cellulitis. Area size of a 50 cent piece. Treated with ice, OTC NSAIDs, cephalexin 500mg Q 6 hrs x 7 days.
?Covid arm?. Slight red rash, very warm to touch (about 4 inches diameter), slight swelling, painful to touch or when raising arm, occasional feeling of internal itching
This spontaneous report as received from a medical assistant refers to a female patient in her mid fifties. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 07-NOV-2017, the patient was vaccinated with one dose of PNEUMOVAX 23, injection, subcutaneously (frequency, lot # and expiration date were not reported) for prophylaxis. The medical assistant stated that the dose of the vaccine was administered into the fat on the back of an unspecified arm, not into the deltoid. On the same day, the patient experienced bruising on the arm at the injection site. The patient did not seek medical attention and no treatment was given for the event. The outcome of the event was reported as not recovered. The relatedness between the event and the suspected vaccine was unknown.
I received a third booster of Moderna Bivalent for COVID-19 on 9/8/2022. At around 6:15PM on 9/13/2022, I had a runny nose and a sore and swollen left tonsil. An acquaintance of mine had recently tested positive for COVID-19, so I decided to take a home test, and I got a positive result when I did. I decided that I needed to get an antiviral, as I have asthma, and I wanted to reduce my risk of having severe symptoms. I contacted an online source for visitless prescriptions and received a prescription for molnupiravir, which I started taking on 9/14/2022. On 9/14/2022, I was bedridden and extremely fatigued. I ran a fever that was 102 at its peak, and I treated this with Tylenol; the Tylenol helped relieve the fever somewhat, but it always returned once the medicine wore off. For about 36 hours, I had the fever off and on. I also had an extremely runny nose. It was so runny that it was literally a constant stream, and I never experienced this with any of my previous illnesses. I had a severe headache that lasted for about 4 days; I took Excedrin for a couple of days, and it helped a little. I then took a prescription medication for migraines, and it finally relieved it.  I had a cough, which was relatively mild. I had brain fog, which lasted for more than 5 days. The fatigue also lasted for more than 5 days, and at the time of this writing, I still haven't regained my pre-COVID energy level. I get tired earlier in the evening than I used to as a result of this. When the fever finally broke on the evening of 9/15/2022, I began to feel better. I continued to improve. By 9/18/2022, I had finished taking the molnupiravir. Aside from the residual fatigue and mild cough, I pretty much felt normal again. On 9/20/2022, I took another home test and got a negative result.
About two hours after getting the vaccine I started having flu like symptoms. The arm where I got the shot started aching, it felt a lot like tennis elbow. I got waves of intense nausea. My nose began running. I developed a sore throat.  I got waves of light headedness, occasionally feeling like I may pass out. And I was extremely thirsty. No matter how much water I drank, my mouth was dry and I felt severely dehydrated. This lasted for about three and a half hours and then passed and I felt normal again.
A non-serious spontaneous report of administered expired FLUMIST was received from a health professional concerning a five-year-old female patient. Neither relevant medical history nor concomitant medications have been reported for this patient. The vaccine expired on 22-Nov-2011. The patient received the expired FLUMIST on 16-Dec-2010. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event is considered resolved. Additional information was received on 04-Apr-2011: The patient did not have any late occurring adverse events.
This spontaneous report was received form a registered nurse concerning an unspecified number of patients (ages and genders not specified). The nurse reported that the unspecified number of patients were administered GARDASIL, ROTATEQ, PNEUMOVAX 23 and (Merck) VARIVAX that were improperly stored. There were no adverse effects. Additional information is not expected.
pt admitted to hospital with COVID pneumonia, acute UTI, AHRF; treated with Zosyn, dexamethasone, baricitinib; increasing O2 requirements; Optiflow NRB; DNI/DNR; refused aggressive care or transport; pt's condition declined and she died in the hospital
Know at injection site; growing red and swollen; patient reports discomfort in entire arm when she presented to the pharmacy 1/14/17.
This spontaneous report was received from a pharmacist and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, concomitant medications and drug reactions or allergies was provided. On 12-DEC-2018, the patient was vaccinated with VARIVAX lot # R017641, expiration date 20-JUN-2020, intramuscularly (dose, dose number and anatomical location were not provided). The VARIVAX was reconstituted with sterile diluent, lot number M024765, expiration date 20-FEB-2019. The outcome of incorrect route of product administration and no adverse event was unknown.
Arm edema; This case was reported by a pharmacist via call center representative and described the occurrence of edema arms in a 64-year-old female patient who received Flu unspecified (Flu vaccine) for prophylaxis.   On an unknown date, the patient received Flu vaccine. On an unknown date, unknown after receiving Flu vaccine, the patient experienced edema arms. On an unknown date, the outcome of the edema arms was unknown.   It was unknown if the reporter considered the edema arms to be related to Flu vaccine.     Additional Information: GSK Receipt Date: 12-SEP-2022 Reporter's Comment: The pharmacist reported that the patient received Flu vaccinations in the past (manufacturer was unknown) and developed arm edema. The reporter did not consent to follow up.
A little soreness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (A little soreness at the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No prior medical history was reported.).    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced VACCINATION SITE PAIN (A little soreness at the injection site). On 19-Feb-2021, VACCINATION SITE PAIN (A little soreness at the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported.  Treatment information was not provided.   The reporter wish to know whether she can have cocktail.
tested positive for Covid19; tested positive for Covid19; chills; nausea; headache; Loss of smell; This is a spontaneous report from a Pfizer Sponsored Program Pfizer. A contactable female consumer of an unspecified age reported for herself that she received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 11Jan2021 at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced tested positive for covid-19 on unspecified date, chills, nausea, headache, loss of smell on 13Jan2021 with outcome of unknown. Patient second dose of Covid will be on 02Feb2021.   Information on Lot/batch number has been requested.
I received my second Pfizer booster for COVID-19 on 2/18/2022. On about 2/20/2022, I woke up and found that I wasn't feeling right. My memory wasn't what it normally is, and my mental functioning was off to the point where I felt like I had possibly had a stroke. I also had involuntary movements. For example, when I was trying to put in eye drops, I tapped my head instead of tapping the bottle. These symptoms continued for 10-14 days, though they gradually diminished. I saw my NP on 3/7/2022 to discuss my symptoms, and I underwent an MRI on 3/23/2022, and anomalies were detected in the image. I saw a neurologist on 4/14/2022, and he reviewed the results of the MRI. He felt that the anomalies that were detected were the result of the machine rather than any physical abnormalities I had. He conducted 15-20 minutes of neurological tests that included memory tests, comprehension tests, and physical coordination tests. He also inquired about my family history and whether I had had seizure symptoms. The neurologist concluded that the symptoms I developed on 2/20/2022 were the result of an overstimulated immune system. He also determined that I was doing fine when he tested me. He instructed me that should the symptoms return or worsen, I was to contact him. At the time of this writing, I would say that I have made a 95% recovery from my symptoms. I still have a little trouble tracking mentally.
Hepatitis B surface antigen positive. This case was reported by a physician and described a 54-year-old patient who received hepatitis B vaccine recombinant (Engerix-B) and subsequently tested positive for hepatitis B surface antigen. Medical history included renal failure (cause not specified) requiring hemodialysis. On 07 January 2004, prior to immunization with Engerix-B, the patient tested negative for hepatitis B surface antigen and hepatitis B surface antibody. On 23 August 2004, the patient received the first dose of Engerix-B (Lot AHBVA077AB). Approximately two days later, on 25 August, the patient tested positive for hepatitis B surface antigen. The patient received the second dose of Engerix-B on 15 September 2004 (lot AHBVA077AB). Approximately two weeks later, on 29 September 2004, a repeat test for hepatitis B surface antigen was negative. The reporting physician considered the event to be related to vaccination with Engerix-B.
gave FLUBLOK to 15 years old patient/ No AE; Initial information received on 16-Oct-2020 regarding an unsolicited valid non-serious case received from the other health care professional.  This case involves a 15 years old male patient who received a dose of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV] (lot number and expiry date: not reported) via an unknown route and site on unknown date for prophylactic vaccination (product administered to patient of inappropriate age).   The patient's medical history, medical treatments, concomitant therapy, vaccinations and family history were not provided.  It was an actual medication error due to inappropriate age at vaccine administration (latency: same day at the time of vaccination).  At the time of reporting, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  There will be no information on the lot number for this case.
From initial information received on 19Nov04 from a health care professional regarding an adverse event occurring it was reported that a four month old male pt received a dose of Daptacel, lot number C1700AA, administered in the left thigh; a dose of Acthib, lot number UE395AA, administered in the left thigh; a dose of Ipol, lot number X1212 (site of administration not reported) and a dose of Prevnar, lot number A57562A, administered in the right thigh on 11Nov04. The routes of administration were not reported. An unspecified amount of time later, the pt developed redness at the site of the injection, but the exact site was not specified. It is unk whether he recovered from this event. The reporter of this case is the same reporter as cases 200403769, 200403770, 200403772, 200403773 and 200403774.
Pt received vaccine Monday, Weds pt started having pain at site, redness, warmth.
swelling; red rash; hot; localized reaction; This spontaneous case was reported by a physician and describes the occurrence of SWELLING (swelling), RASH ERYTHEMATOUS (red rash), FEELING HOT (hot) and UNEVALUABLE EVENT (localized reaction) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SWELLING (swelling), RASH ERYTHEMATOUS (red rash), FEELING HOT (hot) and UNEVALUABLE EVENT (localized reaction). At the time of the report, SWELLING (swelling), RASH ERYTHEMATOUS (red rash), FEELING HOT (hot) and UNEVALUABLE EVENT (localized reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
immediately after getting the pfizer shot, patient started to have chest pressure, difficulty breathing, lightheadedness, and sweating.  pharmacist gave patient 1gm of acetaminophen and monitor for 30 minutes.  patient went to ER right after and was given Toradol for pain, 324 mg of Aspirin for chest tightness, and 2 other medications for allergic reaction. Heart labs, and xray had no findings.  the next day 29 Sep 21 patient followed up with clinic.  work up given as patient had chest pain.  xray showed inflamed bronchus and upper airway, labs had additional titers to Covid Pneumonia and patient was put on antibiotics x4 days.  patient currently has chest pressure to lower lung area with mild difficulty breathing.  patient has follow up scheduled for tomorrow 7 Oct 2021.
Pt given vaccine on 7/7/05. Called and complained of pain on 7/15/05. States he is unable to sleep on R arm and rates pain 9 on 1-10 scale, denies numbness and tingling. Pt states complaint of itching on 7/8/05.
pt recvd vax & exp burning upon inject site, & flu like symptoms after vax;
chills; fever; real bad headaches (severe headaches); her arm still hurts; side effects; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), PYREXIA (fever), HEADACHE (real bad headaches (severe headaches)), VACCINATION SITE PAIN (her arm still hurts) and ADVERSE REACTION (side effects) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHILLS (chills), PYREXIA (fever), HEADACHE (real bad headaches (severe headaches)), VACCINATION SITE PAIN (her arm still hurts) and ADVERSE REACTION (side effects). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. At the time of the report, CHILLS (chills), PYREXIA (fever), HEADACHE (real bad headaches (severe headaches)), VACCINATION SITE PAIN (her arm still hurts) and ADVERSE REACTION (side effects) outcome was unknown. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication was not provided.
Continuous Post nasal drip started right after vaccine and has not gone away after 11 days.  Also, my body is bloated and that has not gone away.  I was very thirsty after the vaccine so I drank a lot of water.  The bloat does not seem to be lessening.  It is very uncomfortable.  I don't want to get the second dose of the vaccine if this does not go away as I am afraid it will get worse.    Although you do not have that as a side effect of the vaccine there are a lot of other symptoms you do not have but I have heard many people say they get these symptoms after the vaccine.  You do not make it easy for people to report their symptoms so how are you keeping track of the symptoms people are experiencing after the vaccine.  Most older people are not computer literate and even though I am it was not easy to find out how to report these symptoms.  They gave me some way of reporting it by text message but I have an older phone and it won't work on that.  Most older people would not report symptoms on a phone....they are too small.  I also have an ipad but it does not do text messages.  I suggest you find another way to track symptoms after the vaccine or you are not getting accurate information.  This is not the way to do science.
Adverse Event/symptoms started approx 12 hrs after receiving Pneumonia vaccine on 9/24/2011 and subsided by Wed 27Sept 2011.  Symptoms included red, swelling, hard to the touch, and hot to the touch. States swelling was from injection site to her elbow and 1/2 way around her arm. Denies systemic fever.  Treatment rendered warm compress to the site, and Tylenol. Treatment rendered by patient herself. Patient reports she received a previous Pneumonia vaccine 7 years ago.
Severe muscle ache across the shoulder and neck area. Gets worse for the 24 hours after the dose and then improves till the next dose. Upset stomach and abdominal cramping started on Day 3 and lasted for 48 hours.
Each time I received a Covid shot - 03/29/21 and 04/26/2021 - I developed joint pain - on the days I received the shots, the joint pain happened at night and for a few weeks after. It got better and then only happened on occasion. When I received the booster shot, it happened again..the pain I had that night was excruciating. All my joints hurt...ankles, hips, knees , elbows, wrists fingers, shoulders. This time the pain has not really went away. I continue to have pain at night and during the day in various joints.  They are now offering another booster for people over 50. I will opt out of this shot. I can directly relate the joint pain to the Covid shot. I am not willing to risk getting another one of these vaccines due to the joint pain caused by the previous vaccines.
This spontaneous report as received from a pharmacist refers to a 63 year old female patient. On 16-MAR the patient was subcutaneously vaccinated with a dose of 0.65 ml ZOSTAVAX (lot # H019035, expiry date 17-JAN-2014). No other co-suspects products were reported. No concomitant medications were reported. On 17-MAR-2013, the patient experienced redness, swelling, itchy, and around the injection site it was sore. The patient had sought medical attention via calling pharmacy. The patient was not given the treatment for the adverse events. There were no laboratory diagnostics studies performed. The outcome of redness, swelling, itchy, and around the injection site it was sore was reported as recovering/resolving. The pharmacist wanted a lot check. This is one of several reports from the same source. Additional information has been requested.